Sollinda Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,677
Closed -$239K 103
2023
Q4
$239K Buy
+2,677
New +$239K 0.07% 76